FIELD: chemistry.
SUBSTANCE: claimed invention relates to novel co-crystal, containing (rac)-tramadol HCl and celecoxib, with respective molecular ratio 1:1. Co-crystal can be used for treating pain, preferably acute pain, chronic pain, neuropathic pain, noticetive pain, minor and from severe to moderate pain, hyperalgesia, pain, associated with central sensitisation, allodynia or cancer pain, including diabetic neuropathy or diabetic peripheral neuropathy and osteoarthritis, fibromyalgia; rheumatois arthritis, ankylosing spondilitis, glenohumeral periarthritis or ischias. Co-crystal is characterised by peaks of powder X-ray diffraction, obtained with application of copper (CuKα1 1.54060 E), and irradiation and absorption bands of infrared spectra. Co-crystal has orthorhombic elementary cell with the following dimensions: a=11.0323 (7) E,b=18.1095 (12) E,c=17.3206 (12) E, as well as endothermic acute peak, corresponding to melt point, with start at 164°C.
EFFECT: invention also relates to method of obtaining co-crystal and based on it pharmaceutical composition.
8 cl, 9 dwg, 3 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL COMPOSITIONS OF COCRYSTALS OF TRAMADOL AND COXIBS | 2011 |
|
RU2567843C2 |
CO-CRYSTALLINE FORMS OF TRAMADOL AND NSAID | 2009 |
|
RU2599717C2 |
COMPOSITIONS COMPRISING TRAMADOL AND CELECOXIB FOR TREATING PAIN | 2010 |
|
RU2707752C2 |
SIMULTANEOUS, SEPARATE OR SEPARATED IN TIME THERAPEUTIC APPLICATION OF, AT LEAST, ONE BOTULIC NEUROTOXIN AND, AT LEAST, ONE OPIATE DERIVATIVE | 2007 |
|
RU2434637C2 |
APPLICATION OF DIHYDROMIDASOPIRAZINE FOR PAIN PREVENTION OR MANAGEMENT | 2005 |
|
RU2388474C2 |
COMBINATIONS OF PALMITOYLETHANOLAMIDE FOR TREATING CHRONIC PAIN | 2018 |
|
RU2701720C1 |
(S)-PIRLINDOLE AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS FOR USE IN MEDICINE | 2014 |
|
RU2695647C2 |
PREGNANDIONS OR PREGNANDIOLS APPLICATION AS NEUROPATHIC ANALGESIC AGENTS | 2002 |
|
RU2346690C2 |
SIGMA LIGANDS FOR POTENTIATING ANALGESIC EFFECT OF OPIOIDS AND OPIATES IN POSTOPERATIVE PAIN AND ATTENUATING DEPENDENCY THEREOF | 2011 |
|
RU2563460C2 |
USE OF CARBAMATE COMPOUND FOR PREVENTION, RELIEF, OR TREATMENT OF DIABETIC PERIPHERAL NEUROPATHY OR PERIPHERAL NEUROPATHY INDUCED BY CHEMOTHERAPY | 2019 |
|
RU2783733C1 |
Authors
Dates
2015-04-10—Published
2010-04-19—Filed